Assessment of bioactive metabolites and hypolipidemic effect of polyphenolic-rich red cabbage extract

Context: Cardiovascular disease is the leading cause of death worldwide and the consumption of red cabbage (Brassica oleracea var. capitata f. rubra DC. - Brassicaceae) has been linked with the reduction risk of chronic diseases. Objective: The present study assesses the bioactive metabolites and hy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical biology 2016-12, Vol.54 (12), p.3033-3039
Hauptverfasser: Cruz, Alice Buss, Pitz, Heloísa da Silva, Veber, Bruno, Bini, Larissa Alida, Maraschin, Marcelo, Zeni, Ana Lúcia Bertarello
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3039
container_issue 12
container_start_page 3033
container_title Pharmaceutical biology
container_volume 54
creator Cruz, Alice Buss
Pitz, Heloísa da Silva
Veber, Bruno
Bini, Larissa Alida
Maraschin, Marcelo
Zeni, Ana Lúcia Bertarello
description Context: Cardiovascular disease is the leading cause of death worldwide and the consumption of red cabbage (Brassica oleracea var. capitata f. rubra DC. - Brassicaceae) has been linked with the reduction risk of chronic diseases. Objective: The present study assesses the bioactive metabolites and hypolipidemic effect of red cabbage on rats. Materials and methods: The content of total phenols, flavonoids, anthocyanins, carotenoids, ascorbic acid and antioxidant capacity were assessed, while individual phenolic acids and flavonoids were detected using reverse phase-high performance liquid chromatography (HPLC) analysis. Acute hypolipidemic activity of aqueous extract of red cabbage (RC - 125, 250 and 500 mg/kg) was investigated using a Triton WR-1339 (400 mg/kg) induced hyperlipidemic Wistar rats compared to fenofibrate (65 mg/kg). Results: The HPLC analysis of extracts revealed eight phenolic acids, gallic, protocatechuic, p-hydroxybenzoic, m-coumaric, syringic, caffeic, cinnamic, dicaffeoylquinic and three flavonoids, epicatechin, epigallocatechin, gallocatechin. Furthermore, the aqueous extract showed higher amounts of total phenolics (116.00 mg/g), flavonoids (161.32 μg/g) and, antioxidant activity (87.19%) than the hydromethanolic (89.33 mg/g, 123.34 μg/g and 75.07%), respectively. The RC significantly (p 
doi_str_mv 10.1080/13880209.2016.1200633
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmed_primary_27436527</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>27436527</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-3d5f3a4169d13cea0348177c2a67c6c7546f44be55729e6f0e04bc8ba7289fe43</originalsourceid><addsrcrecordid>eNp9kMlOwzAURS0EolD4BJB_IMWzkx1VxSRVYgPryHaeqVEm2WHI35PSliWrN917n3QQuqJkQUlObijPc8JIsWCEqgVlhCjOj9AZ1UJkklJ1PPWTJtuKZug8pXdCiORcnqIZ04IryfQZgmVKkFID7YA7j23ojBvCJ-AGBmO7OgyQsGkrvBn7aepDBU1wGLwH9-uYtmO_gXY6uiwGt8ERKuyMteYNMHwPcQq8QCfe1Aku93WOXu_vXlaP2fr54Wm1XGdOUD5kvJKeG0FVUVHuwBAucqq1Y0Zpp5yWQnkhLEipWQHKEyDCutwazfLCg-BzJHe5LnYpRfBlH0Nj4lhSUm6xlQds5RZbucc2-a53vv7DNlD9uQ6cJsHtThBa38XGfHWxrsrBjHUXfTStC6nk___4AZ95fcM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Assessment of bioactive metabolites and hypolipidemic effect of polyphenolic-rich red cabbage extract</title><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Cruz, Alice Buss ; Pitz, Heloísa da Silva ; Veber, Bruno ; Bini, Larissa Alida ; Maraschin, Marcelo ; Zeni, Ana Lúcia Bertarello</creator><creatorcontrib>Cruz, Alice Buss ; Pitz, Heloísa da Silva ; Veber, Bruno ; Bini, Larissa Alida ; Maraschin, Marcelo ; Zeni, Ana Lúcia Bertarello</creatorcontrib><description>Context: Cardiovascular disease is the leading cause of death worldwide and the consumption of red cabbage (Brassica oleracea var. capitata f. rubra DC. - Brassicaceae) has been linked with the reduction risk of chronic diseases. Objective: The present study assesses the bioactive metabolites and hypolipidemic effect of red cabbage on rats. Materials and methods: The content of total phenols, flavonoids, anthocyanins, carotenoids, ascorbic acid and antioxidant capacity were assessed, while individual phenolic acids and flavonoids were detected using reverse phase-high performance liquid chromatography (HPLC) analysis. Acute hypolipidemic activity of aqueous extract of red cabbage (RC - 125, 250 and 500 mg/kg) was investigated using a Triton WR-1339 (400 mg/kg) induced hyperlipidemic Wistar rats compared to fenofibrate (65 mg/kg). Results: The HPLC analysis of extracts revealed eight phenolic acids, gallic, protocatechuic, p-hydroxybenzoic, m-coumaric, syringic, caffeic, cinnamic, dicaffeoylquinic and three flavonoids, epicatechin, epigallocatechin, gallocatechin. Furthermore, the aqueous extract showed higher amounts of total phenolics (116.00 mg/g), flavonoids (161.32 μg/g) and, antioxidant activity (87.19%) than the hydromethanolic (89.33 mg/g, 123.34 μg/g and 75.07%), respectively. The RC significantly (p &lt; 0.001) ameliorated the levels of cholesterol, triglycerides and lipoproteins alterations in hyperlipidemic rats without toxicity. Discussion and conclusion: Herein, the RC presented the higher amounts of phenolics and flavonoids comparing with the hydromethanolic extract. Additionally, the RC showed as the majority compounds, dicaffeoylquinic and cinnamic acids, and the flavonoids epicatechin and gallocatechin. Furthermore, the RC demonstrated a beneficial effect against hypercholesterolemia and hypertriglyceridemia, demonstrating its potential therapeutic effect on these risk factors of cardiovascular diseases.</description><identifier>ISSN: 1388-0209</identifier><identifier>EISSN: 1744-5116</identifier><identifier>DOI: 10.1080/13880209.2016.1200633</identifier><identifier>PMID: 27436527</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>Animals ; Bioactive compounds ; Brassica ; Brassica oleareacea ; Cholesterol - blood ; Dose-Response Relationship, Drug ; Hyperlipidemias - blood ; Hyperlipidemias - drug therapy ; Hypolipidemic Agents - isolation &amp; purification ; Hypolipidemic Agents - pharmacology ; Hypolipidemic Agents - therapeutic use ; hypolipidemic effect ; lipid profile ; phenolics ; Phytochemicals - isolation &amp; purification ; Phytochemicals - pharmacology ; Phytochemicals - therapeutic use ; Plant Extracts - isolation &amp; purification ; Plant Extracts - pharmacology ; Plant Extracts - therapeutic use ; Polyphenols - isolation &amp; purification ; Polyphenols - pharmacology ; Polyphenols - therapeutic use ; Rats ; Rats, Wistar ; Treatment Outcome ; Triglycerides - antagonists &amp; inhibitors ; Triglycerides - blood ; Triton WR-1339</subject><ispartof>Pharmaceutical biology, 2016-12, Vol.54 (12), p.3033-3039</ispartof><rights>2016 Informa UK Limited, trading as Taylor &amp; Francis Group 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-3d5f3a4169d13cea0348177c2a67c6c7546f44be55729e6f0e04bc8ba7289fe43</citedby><cites>FETCH-LOGICAL-c413t-3d5f3a4169d13cea0348177c2a67c6c7546f44be55729e6f0e04bc8ba7289fe43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27436527$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cruz, Alice Buss</creatorcontrib><creatorcontrib>Pitz, Heloísa da Silva</creatorcontrib><creatorcontrib>Veber, Bruno</creatorcontrib><creatorcontrib>Bini, Larissa Alida</creatorcontrib><creatorcontrib>Maraschin, Marcelo</creatorcontrib><creatorcontrib>Zeni, Ana Lúcia Bertarello</creatorcontrib><title>Assessment of bioactive metabolites and hypolipidemic effect of polyphenolic-rich red cabbage extract</title><title>Pharmaceutical biology</title><addtitle>Pharm Biol</addtitle><description>Context: Cardiovascular disease is the leading cause of death worldwide and the consumption of red cabbage (Brassica oleracea var. capitata f. rubra DC. - Brassicaceae) has been linked with the reduction risk of chronic diseases. Objective: The present study assesses the bioactive metabolites and hypolipidemic effect of red cabbage on rats. Materials and methods: The content of total phenols, flavonoids, anthocyanins, carotenoids, ascorbic acid and antioxidant capacity were assessed, while individual phenolic acids and flavonoids were detected using reverse phase-high performance liquid chromatography (HPLC) analysis. Acute hypolipidemic activity of aqueous extract of red cabbage (RC - 125, 250 and 500 mg/kg) was investigated using a Triton WR-1339 (400 mg/kg) induced hyperlipidemic Wistar rats compared to fenofibrate (65 mg/kg). Results: The HPLC analysis of extracts revealed eight phenolic acids, gallic, protocatechuic, p-hydroxybenzoic, m-coumaric, syringic, caffeic, cinnamic, dicaffeoylquinic and three flavonoids, epicatechin, epigallocatechin, gallocatechin. Furthermore, the aqueous extract showed higher amounts of total phenolics (116.00 mg/g), flavonoids (161.32 μg/g) and, antioxidant activity (87.19%) than the hydromethanolic (89.33 mg/g, 123.34 μg/g and 75.07%), respectively. The RC significantly (p &lt; 0.001) ameliorated the levels of cholesterol, triglycerides and lipoproteins alterations in hyperlipidemic rats without toxicity. Discussion and conclusion: Herein, the RC presented the higher amounts of phenolics and flavonoids comparing with the hydromethanolic extract. Additionally, the RC showed as the majority compounds, dicaffeoylquinic and cinnamic acids, and the flavonoids epicatechin and gallocatechin. Furthermore, the RC demonstrated a beneficial effect against hypercholesterolemia and hypertriglyceridemia, demonstrating its potential therapeutic effect on these risk factors of cardiovascular diseases.</description><subject>Animals</subject><subject>Bioactive compounds</subject><subject>Brassica</subject><subject>Brassica oleareacea</subject><subject>Cholesterol - blood</subject><subject>Dose-Response Relationship, Drug</subject><subject>Hyperlipidemias - blood</subject><subject>Hyperlipidemias - drug therapy</subject><subject>Hypolipidemic Agents - isolation &amp; purification</subject><subject>Hypolipidemic Agents - pharmacology</subject><subject>Hypolipidemic Agents - therapeutic use</subject><subject>hypolipidemic effect</subject><subject>lipid profile</subject><subject>phenolics</subject><subject>Phytochemicals - isolation &amp; purification</subject><subject>Phytochemicals - pharmacology</subject><subject>Phytochemicals - therapeutic use</subject><subject>Plant Extracts - isolation &amp; purification</subject><subject>Plant Extracts - pharmacology</subject><subject>Plant Extracts - therapeutic use</subject><subject>Polyphenols - isolation &amp; purification</subject><subject>Polyphenols - pharmacology</subject><subject>Polyphenols - therapeutic use</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Treatment Outcome</subject><subject>Triglycerides - antagonists &amp; inhibitors</subject><subject>Triglycerides - blood</subject><subject>Triton WR-1339</subject><issn>1388-0209</issn><issn>1744-5116</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlOwzAURS0EolD4BJB_IMWzkx1VxSRVYgPryHaeqVEm2WHI35PSliWrN917n3QQuqJkQUlObijPc8JIsWCEqgVlhCjOj9AZ1UJkklJ1PPWTJtuKZug8pXdCiORcnqIZ04IryfQZgmVKkFID7YA7j23ojBvCJ-AGBmO7OgyQsGkrvBn7aepDBU1wGLwH9-uYtmO_gXY6uiwGt8ERKuyMteYNMHwPcQq8QCfe1Aku93WOXu_vXlaP2fr54Wm1XGdOUD5kvJKeG0FVUVHuwBAucqq1Y0Zpp5yWQnkhLEipWQHKEyDCutwazfLCg-BzJHe5LnYpRfBlH0Nj4lhSUm6xlQds5RZbucc2-a53vv7DNlD9uQ6cJsHtThBa38XGfHWxrsrBjHUXfTStC6nk___4AZ95fcM</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Cruz, Alice Buss</creator><creator>Pitz, Heloísa da Silva</creator><creator>Veber, Bruno</creator><creator>Bini, Larissa Alida</creator><creator>Maraschin, Marcelo</creator><creator>Zeni, Ana Lúcia Bertarello</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20161201</creationdate><title>Assessment of bioactive metabolites and hypolipidemic effect of polyphenolic-rich red cabbage extract</title><author>Cruz, Alice Buss ; Pitz, Heloísa da Silva ; Veber, Bruno ; Bini, Larissa Alida ; Maraschin, Marcelo ; Zeni, Ana Lúcia Bertarello</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-3d5f3a4169d13cea0348177c2a67c6c7546f44be55729e6f0e04bc8ba7289fe43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Bioactive compounds</topic><topic>Brassica</topic><topic>Brassica oleareacea</topic><topic>Cholesterol - blood</topic><topic>Dose-Response Relationship, Drug</topic><topic>Hyperlipidemias - blood</topic><topic>Hyperlipidemias - drug therapy</topic><topic>Hypolipidemic Agents - isolation &amp; purification</topic><topic>Hypolipidemic Agents - pharmacology</topic><topic>Hypolipidemic Agents - therapeutic use</topic><topic>hypolipidemic effect</topic><topic>lipid profile</topic><topic>phenolics</topic><topic>Phytochemicals - isolation &amp; purification</topic><topic>Phytochemicals - pharmacology</topic><topic>Phytochemicals - therapeutic use</topic><topic>Plant Extracts - isolation &amp; purification</topic><topic>Plant Extracts - pharmacology</topic><topic>Plant Extracts - therapeutic use</topic><topic>Polyphenols - isolation &amp; purification</topic><topic>Polyphenols - pharmacology</topic><topic>Polyphenols - therapeutic use</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Treatment Outcome</topic><topic>Triglycerides - antagonists &amp; inhibitors</topic><topic>Triglycerides - blood</topic><topic>Triton WR-1339</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cruz, Alice Buss</creatorcontrib><creatorcontrib>Pitz, Heloísa da Silva</creatorcontrib><creatorcontrib>Veber, Bruno</creatorcontrib><creatorcontrib>Bini, Larissa Alida</creatorcontrib><creatorcontrib>Maraschin, Marcelo</creatorcontrib><creatorcontrib>Zeni, Ana Lúcia Bertarello</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Pharmaceutical biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cruz, Alice Buss</au><au>Pitz, Heloísa da Silva</au><au>Veber, Bruno</au><au>Bini, Larissa Alida</au><au>Maraschin, Marcelo</au><au>Zeni, Ana Lúcia Bertarello</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessment of bioactive metabolites and hypolipidemic effect of polyphenolic-rich red cabbage extract</atitle><jtitle>Pharmaceutical biology</jtitle><addtitle>Pharm Biol</addtitle><date>2016-12-01</date><risdate>2016</risdate><volume>54</volume><issue>12</issue><spage>3033</spage><epage>3039</epage><pages>3033-3039</pages><issn>1388-0209</issn><eissn>1744-5116</eissn><abstract>Context: Cardiovascular disease is the leading cause of death worldwide and the consumption of red cabbage (Brassica oleracea var. capitata f. rubra DC. - Brassicaceae) has been linked with the reduction risk of chronic diseases. Objective: The present study assesses the bioactive metabolites and hypolipidemic effect of red cabbage on rats. Materials and methods: The content of total phenols, flavonoids, anthocyanins, carotenoids, ascorbic acid and antioxidant capacity were assessed, while individual phenolic acids and flavonoids were detected using reverse phase-high performance liquid chromatography (HPLC) analysis. Acute hypolipidemic activity of aqueous extract of red cabbage (RC - 125, 250 and 500 mg/kg) was investigated using a Triton WR-1339 (400 mg/kg) induced hyperlipidemic Wistar rats compared to fenofibrate (65 mg/kg). Results: The HPLC analysis of extracts revealed eight phenolic acids, gallic, protocatechuic, p-hydroxybenzoic, m-coumaric, syringic, caffeic, cinnamic, dicaffeoylquinic and three flavonoids, epicatechin, epigallocatechin, gallocatechin. Furthermore, the aqueous extract showed higher amounts of total phenolics (116.00 mg/g), flavonoids (161.32 μg/g) and, antioxidant activity (87.19%) than the hydromethanolic (89.33 mg/g, 123.34 μg/g and 75.07%), respectively. The RC significantly (p &lt; 0.001) ameliorated the levels of cholesterol, triglycerides and lipoproteins alterations in hyperlipidemic rats without toxicity. Discussion and conclusion: Herein, the RC presented the higher amounts of phenolics and flavonoids comparing with the hydromethanolic extract. Additionally, the RC showed as the majority compounds, dicaffeoylquinic and cinnamic acids, and the flavonoids epicatechin and gallocatechin. Furthermore, the RC demonstrated a beneficial effect against hypercholesterolemia and hypertriglyceridemia, demonstrating its potential therapeutic effect on these risk factors of cardiovascular diseases.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>27436527</pmid><doi>10.1080/13880209.2016.1200633</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1388-0209
ispartof Pharmaceutical biology, 2016-12, Vol.54 (12), p.3033-3039
issn 1388-0209
1744-5116
language eng
recordid cdi_pubmed_primary_27436527
source MEDLINE; PubMed Central; Alma/SFX Local Collection
subjects Animals
Bioactive compounds
Brassica
Brassica oleareacea
Cholesterol - blood
Dose-Response Relationship, Drug
Hyperlipidemias - blood
Hyperlipidemias - drug therapy
Hypolipidemic Agents - isolation & purification
Hypolipidemic Agents - pharmacology
Hypolipidemic Agents - therapeutic use
hypolipidemic effect
lipid profile
phenolics
Phytochemicals - isolation & purification
Phytochemicals - pharmacology
Phytochemicals - therapeutic use
Plant Extracts - isolation & purification
Plant Extracts - pharmacology
Plant Extracts - therapeutic use
Polyphenols - isolation & purification
Polyphenols - pharmacology
Polyphenols - therapeutic use
Rats
Rats, Wistar
Treatment Outcome
Triglycerides - antagonists & inhibitors
Triglycerides - blood
Triton WR-1339
title Assessment of bioactive metabolites and hypolipidemic effect of polyphenolic-rich red cabbage extract
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T17%3A56%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessment%20of%20bioactive%20metabolites%20and%20hypolipidemic%20effect%20of%20polyphenolic-rich%20red%20cabbage%20extract&rft.jtitle=Pharmaceutical%20biology&rft.au=Cruz,%20Alice%20Buss&rft.date=2016-12-01&rft.volume=54&rft.issue=12&rft.spage=3033&rft.epage=3039&rft.pages=3033-3039&rft.issn=1388-0209&rft.eissn=1744-5116&rft_id=info:doi/10.1080/13880209.2016.1200633&rft_dat=%3Cpubmed_cross%3E27436527%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27436527&rfr_iscdi=true